Synaptogenix acquires stake in Cannasoul Analtyics

Synaptogenix announced a new partnership with Cannasoul Analytics in support of research and development of pharmaceutical therapeutics. Cannasoul is founded by the Technion Research & Development Foundation, the commercialization arm of The Technion – Israel Institute of Technology, and cannabis key opinion leader and researcher Professor Dedi Meiri from The Technion. Synaptogenix obtains a preemptive right to fund the further research and commercialization of certain intellectual property, technology, and future products developed by Cannasoul and licensed from The Technion. Synaptogenix has approximately $33M in cash as of June 30. Founded in 1912, The Technion is Israel’s largest center of applied research and a major source of innovation driving the Israeli economy.